Compare ETFs: LABU
LABU
Comparison
Average Return
| Symbol | Year-to-date | 1 Year | 5 Years | 10 Years | Inception |
|---|---|---|---|---|---|
| LABU | -36.70% | -48.14% | -42.65% | -33.31% | -32.75% |
Top 25 Holdings
| LABU - Direxion Daily S&P Biotech Bull 3X Shares | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | n/a | Dreyfus Govt Cash Man Ins | 19.63% |
| 2 | n/a | Goldman Sachs Sterling FixInc Port Inc | 15.71% |
| 3 | n/a | Goldman Sachs Fin Gov 465 Institut | 9.32% |
| 4 | n/a | S&P Biotechnology Select Industry Index Swap | 6.74% |
| 5 | n/a | Dreyfus Trsry Securities Cash Mgmt | 5.24% |
| 6 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.95% |
| 7 | EXAS | Exact Sciences Corporation | 1.84% |
| 8 | BPMC | Blueprint Medicines Corporation | 1.83% |
| 9 | NBIX | Neurocrine Biosciences, Inc. | 1.78% |
| 10 | NTRA | Natera, Inc. | 1.73% |
| 11 | UTHR | United Therapeutics Corporation | 1.64% |
| 12 | INCY | Incyte Corporation | 1.54% |
| 13 | INSM | Insmed Incorporated | 1.54% |
| 14 | GILD | Gilead Sciences, Inc. | 1.49% |
| 15 | BIIB | Biogen Inc. | 1.46% |
| 16 | AMGN | Amgen Inc. | 1.44% |
| 17 | EXEL | Exelixis, Inc. | 1.41% |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 1.40% |
| 19 | ABBV | AbbVie Inc. | 1.37% |
| 20 | MRNA | Moderna, Inc. | 1.24% |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.23% |
| 22 | REGN | Regeneron Pharmaceuticals, Inc. | 1.10% |
| 23 | BBIO | BridgeBio Pharma, Inc. | 1.09% |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 1.07% |
| 25 | RVMD | Revolution Medicines, Inc. | 0.96% |
| View LABU holdings | |||